Live News EARNINGS M impact Jun 22, 2026, 11:30 AM UTC

BBIO Presents Trial Results

BridgeBio presents primary results from Phase 3 PROPEL 3 trial of oral infigratinib for children with achondroplasia

SQUAWKNEWS Updated Jun 22, 2026, 11:30 AM UTC

BBIO - BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026